Patients Cut Off From Cheaper Obesity Drugs as the FDA Halts Sales of Copycats

Diabetic people in the United States have to be very careful because the medicine Ozempic, one of the most popular to control the disease, could be fake.

Patients Cut Off From Cheaper Obesity Drugs as the FDA Halts Sales of Copycats

Hundreds of thousands of Americans stand to soon lose their access to cheaper weight-loss drugs, with a federal crackdown on copycat versions threatening to disrupt treatment and raise costs. The Food and Drug Administration has ordered producers and sellers of the less expensive products to wind down operations in the coming weeks now that it has declared there are no longer shortages of the blockbuster drugs Wegovy and Zepbound. Produced throu…